Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetes.
Barreto J, Wolf V, Bonilha I, Luchiari B, Lima M, Oliveira A, Vitte S, Machado G, Cunha J, Borges C, Munhoz D, Fernandes V, Kimura-Medorima ST, Breder I, Fernandez MD, Quinaglia T, Oliveira RB, Chaves F, Arieta C, Guerra-Júnior G, Avila S, Nadruz W, Carvalho LSF, Sposito AC; Brazilian Heart Study Group. Barreto J, et al. Among authors: luchiari b. Curr Med Res Opin. 2022 Apr;38(4):523-529. doi: 10.1080/03007995.2022.2043658. Epub 2022 Mar 2. Curr Med Res Opin. 2022. PMID: 35174749
Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis.
Barreto J, Luchiari B, Wolf VLW, Bonilha I, Bovi TG, Assato BS, Breder I, Kimura-Medorima ST, Munhoz DB, Quinaglia T, Coelho-Filho OR, Carvalho LSF, Nadruz W, Sposito AC. Barreto J, et al. Among authors: luchiari b. Diagnostics (Basel). 2022 Mar 26;12(4):814. doi: 10.3390/diagnostics12040814. Diagnostics (Basel). 2022. PMID: 35453862 Free PMC article.
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
Sposito AC, Breder I, Barreto J, Breder J, Bonilha I, Lima M, Oliveira A, Wolf V, Luchiari B, do Carmo HR, Munhoz D, Oliveira D, Coelho-Filho OR, Coelho OR, Matos-Souza JR, Moura FA, de Carvalho LSF, Nadruz W, Quinaglia T, Kimura-Medorima ST; EXCEED-BHS3 Group. Sposito AC, et al. Among authors: luchiari b. Cardiovasc Diabetol. 2022 Aug 6;21(1):147. doi: 10.1186/s12933-022-01584-8. Cardiovasc Diabetol. 2022. PMID: 35933413 Free PMC article. Clinical Trial.
Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years.
Cintra RM, Nogueira AC, Bonilha I, Luchiari BM, Coelho-Filho OR, Coelho OR, Schwartzmann P, Muscellie E, Nadruz W, Carvalho LSF, Sposito AC. Cintra RM, et al. Among authors: luchiari bm. J Clin Endocrinol Metab. 2021 Sep 27;106(10):3060-3067. doi: 10.1210/clinem/dgab428. J Clin Endocrinol Metab. 2021. PMID: 34125217
Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis.
de Carvalho LSF, Nogueira ACC, Bonilha I, Luchiari B, Benchimol A, Couri CEB, Borges JL, Barreto J, Sposito AC. de Carvalho LSF, et al. Among authors: luchiari b. Front Cardiovasc Med. 2022 Apr 29;9:876795. doi: 10.3389/fcvm.2022.876795. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35571207 Free PMC article.
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Nogueira ACC, Barreto J, Moura FA, Luchiari B, Abuhab A, Bonilha I, Nadruz W, Gaziano JM, Gaziano T, de Carvalho LSF, Sposito AC; Brazilian Heart Study Group. Nogueira ACC, et al. Among authors: luchiari b. Health Econ Rev. 2023 Oct 25;13(1):50. doi: 10.1186/s13561-023-00466-3. Health Econ Rev. 2023. PMID: 37878108 Free PMC article.
Very low HDL levels: clinical assessment and management.
Bonilha I, Luchiari B, Nadruz W, Sposito AC. Bonilha I, et al. Among authors: luchiari b. Arch Endocrinol Metab. 2023 Jan 18;67(1):3-18. doi: 10.20945/2359-3997000000585. Arch Endocrinol Metab. 2023. PMID: 36651718 Free PMC article. Review.
Aspirin in primary prevention and the risk of heart failure: a systematic review and meta-analysis of controlled trials.
de Oliveira ABM, Luchiari B, Bonilha I, Barreto J, Nogueira ACC, Ceniccola GD, Polanczyk CA, Sposito AC, de Carvalho LSF. de Oliveira ABM, et al. Among authors: luchiari b. ESC Heart Fail. 2023 Apr;10(2):1488-1491. doi: 10.1002/ehf2.14269. Epub 2022 Dec 26. ESC Heart Fail. 2023. PMID: 36572648 Free PMC article. No abstract available.